OpenLegislation

Commission Decision of 29 March 2006 declaring a concentration compatible with the common market and the functioning of the EEA Agreement (Case COMP/M.3975 — Cargill/Degussa) (notified under document number C(2006) 1034) (Only the English version is authentic) (Text with EEA relevance) (2007/783/EC) (revoked)

EU Decision 2007/783 · Adopted 29 March 2006 · Extends to United Kingdom

Original text. legislation.gov.uk does not revise this item, so later amendments are not shown here. Changes made to it are listed under each provision when known.

Commission Decision

of 29 March 2006

declaring a concentration compatible with the common market and the functioning of the EEA Agreement

(Case COMP/M.3975 — Cargill/Degussa)

(notified under document number C(2006) 1034)

(Only the English version is authentic)

(Text with EEA relevance)

(2007/783/EC) (revoked)

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

On 29 March 2006 the Commission adopted a Decision in a merger case under Council Regulation (EC) No 139/2004 of 20 January 2004 on the control of concentrations between undertakings, and in particular Article 8(1) of that Regulation. A non-confidential version of the full decision can be found in the authentic language of the case and in the working languages of the Commission on the website of the Directorate-General for Competition, at the following address: http://ec.europa.eu/comm/competition/index_en.html

Annotations to the whole text

Textual amendments

F1

Decision revoked (31.12.2020) by The Competition (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/93), reg. 1(1), Sch. 3 para. 2 (as amended by S.I. 2020/1343, reg. 34(3)); 2020 c. 1, Sch. 5 para. 1(1)

Contents

  1. ISUMMARY Repealed
  2. (1)Division (1) Repealed
  3. (2)Division (2) Repealed
  4. (3)Division (3) Repealed
  5. (4)Division (4) Repealed
  6. IITHE PARTIES AND THE OPERATION Repealed
  7. (5)Division (5) Repealed
  8. IIICONCENTRATION WITH COMMUNITY DIMENSION Repealed
  9. (6)Division (6) Repealed
  10. IVTHE RELEVANT PRODUCT MARKETS Repealed
  11. (7)Division (7) Repealed
  12. 1The different lecithin markets Repealed
  13. (8)Division (8) Repealed
  14. (9)Division (9) Repealed
  15. (a)Lecithin and synthetic emulsifiers are not on the same product market Repealed
  16. (10)Division (10) Repealed
  17. (11)Division (11) Repealed
  18. (b)GM and non-GM lecithin have to be assessed separately Repealed
  19. (12)Division (12) Repealed
  20. (13)Division (13) Repealed
  21. (c)Fluid, deoiled and fractionated lecithin have to be assessed separately Repealed
  22. (14)Division (14) Repealed
  23. (15)Division (15) Repealed
  24. 2Pectin Repealed
  25. (16)Division (16) Repealed
  26. VTHE RELEVANT GEOGRAPHIC MARKETS Repealed
  27. 1Lecithin Repealed
  28. (17)Division (17) Repealed
  29. (18)Division (18) Repealed
  30. (19)Division (19) Repealed
  31. 2Pectin Repealed
  32. (20)Division (20) Repealed
  33. VIASSESSMENT Repealed
  34. 1Non-GM fluid lecithin Repealed
  35. (21)Division (21) Repealed
  36. (22)Division (22) Repealed
  37. (23)Division (23) Repealed
  38. (24)Division (24) Repealed
  39. 2Non-GM deoiled lecithin Repealed
  40. (25)Division (25) Repealed
  41. (26)Division (26) Repealed
  42. (27)Division (27) Repealed
  43. (28)Division (28) Repealed
  44. (29)Division (29) Repealed
  45. 3GM lecithin markets Repealed
  46. (30)Division (30) Repealed
  47. 4Pectin Repealed
  48. (31)Division (31) Repealed
  49. 5Vertical effects (crude seed oil) Repealed
  50. (32)Division (32) Repealed
  51. VIICONCLUSION Repealed
  52. (33)Division (33) Repealed
  53. (34)Division (34) Repealed

ISUMMARYF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(1)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(2)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(3)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(4)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

IITHE PARTIES AND THE OPERATIONF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(5)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

IIICONCENTRATION WITH COMMUNITY DIMENSIONF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(6)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

IVTHE RELEVANT PRODUCT MARKETSF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(7)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1The different lecithin marketsF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(8)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(9)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(a)Lecithin and synthetic emulsifiers are not on the same product marketF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(10)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(11)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(b)GM and non-GM lecithin have to be assessed separatelyF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(12)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(13)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(c)Fluid, deoiled and fractionated lecithin have to be assessed separatelyF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(14)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(15)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2PectinF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(16)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

VTHE RELEVANT GEOGRAPHIC MARKETSF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1LecithinF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(17)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(18)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(19)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2PectinF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(20)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

VIASSESSMENTF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1Non-GM fluid lecithinF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(21)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(22)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(23)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(24)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2Non-GM deoiled lecithinF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(25)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(26)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(27)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(28)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(29)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

3GM lecithin marketsF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(30)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

4PectinF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(31)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

5Vertical effects (crude seed oil)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(32)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

VIICONCLUSIONF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(33)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(34)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .